Effects of dapagliflozin on postprandial lipid metabolism in type 2 diabetes mellitus

Burggraaf, B; Pouw, NMC; Arroyo, SF; Van Vark-van der Zee, LC; Van de Geijn, GJM; Birnie, E; Huisbrink, J; van der Zwan, EM; de Herder, WW; Mulder, MT; Rensen, PCN; Cabezas, MC

Burggraaf, B (通讯作者),Franciscus Gasthuis & Vlietland, Ctr Endocrinol Diabet & Vasc Med, Dept Internal Med, Rotterdam, Netherlands.

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2022; 186 (5): 597

Abstract

Objectives: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) modulate lipid metabolism and improve cardiovascular morbidity and mortality in patient......

Full Text Link